Fulcrum Therapeutics (FULC)
(Delayed Data from NSDQ)
$7.28 USD
-0.16 (-2.15%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $7.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | 9.09% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.76 |
Next Year | -1.74 |
EPS (TTM) | -1.58 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.92M | 0.96M | 3.94M | 42.88M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.92M | 0.96M | 3.94M | 42.88M |
Low Estimate | 0.92M | 0.96M | 3.94M | 42.88M |
Year ago Sales | 0.30M | 0.88M | 2.81M | 3.94M |
Year over Year Growth Est. | 206.67% | 9.09% | 40.46% | 988.32% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.44 | -1.76 | -1.74 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | -0.40 | -0.40 | -1.63 | -1.11 |
High Estimate | -0.40 | -0.40 | -1.59 | -1.11 |
Low Estimate | -0.46 | -0.47 | -1.93 | -2.07 |
Year ago EPS | -0.41 | -0.38 | -1.59 | -1.76 |
Year over Year Growth Est. | -7.32% | -15.79% | -10.69% | 1.14% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 3 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.44 | -1.76 | -1.74 |
7 Days Ago | -0.44 | -0.44 | -1.76 | -1.74 |
30 Days Ago | -0.44 | -0.44 | -1.76 | -1.74 |
60 Days Ago | -0.44 | -0.44 | -1.77 | -1.56 |
90 Days Ago | -0.44 | -0.44 | -1.77 | -1.56 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.44 | -1.76 | -1.74 |
Zacks Consensus Estimate | -0.44 | -0.44 | -1.76 | -1.74 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.39 | -0.38 | -0.41 | NA |
Estimate | -0.44 | -0.44 | -0.44 | -0.47 | NA |
Difference | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 |
Surprise | 9.09% | 11.36% | 13.64% | 12.77% | 11.72% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more